216 related articles for article (PubMed ID: 31825351)
21. Surgery on neuroendocrine tumours.
Akerström G; Hellman P
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):87-109. PubMed ID: 17382267
[TBL] [Abstract][Full Text] [Related]
22. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
[TBL] [Abstract][Full Text] [Related]
23. [Gastric neuroendocrine tumors: clinical, endoscopic presentation and alternatives of treatment].
Lazarte R; Poniachik J; Smok G; Contreras J; Gutiérrez L; Csendes A
Rev Med Chil; 2002 Sep; 130(9):985-92. PubMed ID: 12434645
[TBL] [Abstract][Full Text] [Related]
24. Gastric neuroendocrine tumours.
Crosby DA; Donohoe CL; Fitzgerald L; Muldoon C; Hayes B; O'Toole D; Reynolds JV
Dig Surg; 2012; 29(4):331-48. PubMed ID: 23075625
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Evaluations Tailored to Specific Gastric Neuroendocrine Neoplasms: Analysis Of 200 Cases with Extended Follow-Up.
Vanoli A; La Rosa S; Miceli E; Klersy C; Maragliano R; Capuano F; Persichella A; Martino M; Inzani F; Luinetti O; Di Sabatino A; Sessa F; Paulli M; Corazza GR; Rindi G; Bordi C; Capella C; Solcia E
Neuroendocrinology; 2018; 107(2):114-126. PubMed ID: 29895024
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and treatment of ECL cell tumors.
Cadiot G; Cattan D; Mignon M
Yale J Biol Med; 1998; 71(3-4):311-23. PubMed ID: 10461362
[TBL] [Abstract][Full Text] [Related]
27. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?
Cavalcoli F; Zilli A; Conte D; Ciafardini C; Massironi S
Scand J Gastroenterol; 2015; 50(11):1397-403. PubMed ID: 26059834
[TBL] [Abstract][Full Text] [Related]
28. Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh VQ; Shi C; Ma C
Histopathology; 2020 Dec; 77(6):865-876. PubMed ID: 32702178
[TBL] [Abstract][Full Text] [Related]
29. Multiple endocrine neoplasia type 1 with Zollinger-Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry.
Kimura N; Hirata Y; Iwashiro N; Kijima H; Takayasu S; Yamagata S; Sakihara S; Uchino S; Ohara M
Front Endocrinol (Lausanne); 2023; 14():1221514. PubMed ID: 37867522
[TBL] [Abstract][Full Text] [Related]
30. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
31. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis.
Guillem P; Vlaeminck-Guillem V
Endocrine; 2015 Aug; 49(3):867-8. PubMed ID: 25957667
[No Abstract] [Full Text] [Related]
32. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors.
Solcia E; Rindi G; Paolotti D; Luinetti O; Klersy C; Zangrandi A; La Rosa S; Capella C
Yale J Biol Med; 1998; 71(3-4):285-90. PubMed ID: 10461359
[TBL] [Abstract][Full Text] [Related]
33. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A
Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665
[TBL] [Abstract][Full Text] [Related]
34. Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome.
Schott M; Sagert C; Willenberg HS; Schinner S; Ramp U; Varro A; Raffel A; Eisenberger C; Zacharowski K; Perren A; Scherbaum WA
J Clin Endocrinol Metab; 2007 Sep; 92(9):3378-82. PubMed ID: 17609302
[TBL] [Abstract][Full Text] [Related]
35. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I.
Bordi C; Falchetti A; Azzoni C; D'Adda T; Canavese G; Guariglia A; Santini D; Tomassetti P; Brandi ML
Am J Surg Pathol; 1997 Sep; 21(9):1075-82. PubMed ID: 9298884
[TBL] [Abstract][Full Text] [Related]
36. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior.
Rindi G; Bordi C; Rappel S; La Rosa S; Stolte M; Solcia E
World J Surg; 1996 Feb; 20(2):168-72. PubMed ID: 8661813
[TBL] [Abstract][Full Text] [Related]
37. Risk factors of type 1 gastric neuroendocrine neoplasia in patients with chronic atrophic gastritis. A retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Ricci C; Santini D; Brighi N; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2017 Jun; 56(3):633-638. PubMed ID: 27592118
[TBL] [Abstract][Full Text] [Related]
38. Do Gastric Signet Ring Cell Carcinomas and ECL-Cell Neuroendocrine Tumours Have a Common Origin?
Fossmark R; Johannessen R; Qvigstad G; Mjønes P
Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454309
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
40. [Endocrine cell proliferation of the fundic mucosa in men not associated with hypergastrinemic states].
Bordi C; D'Adda T; Azzoni C; Pilato FP
Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):51C-58C. PubMed ID: 1680768
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]